Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
18 Enero 2023 - 5:07AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2023
Commission File Number: 001-39316
BURNING ROCK BIOTECH LIMITED
(Registrants Name)
No.5 Xingdao
Ring Road North, International Bio Island
Guangzhou, Guangdong
Peoples Republic of China
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form
40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
Burning Rock Biotech Limited |
|
|
By: |
|
/s/ Leo Li |
Name: |
|
Leo Li |
Title: |
|
Chief Financial Officer |
Date: January 18, 2023
3
Burning Rock Biotech (NASDAQ:BNR)
Gráfica de Acción Histórica
De Ene 2025 a Feb 2025
Burning Rock Biotech (NASDAQ:BNR)
Gráfica de Acción Histórica
De Feb 2024 a Feb 2025